178 related articles for article (PubMed ID: 20381452)
1. Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells.
Nagai K; Ishii H; Miyoshi N; Hoshino H; Saito T; Sato T; Tomimaru Y; Kobayashi S; Nagano H; Sekimoto M; Doki Y; Mori M
Biochem Biophys Res Commun; 2010 Apr; 395(2):258-63. PubMed ID: 20381452
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.
Hoshino H; Nagano H; Haraguchi N; Nishikawa S; Tomokuni A; Kano Y; Fukusumi T; Saito T; Ozaki M; Sakai D; Satoh T; Eguchi H; Sekimoto M; Doki Y; Mori M; Ishii H
Int J Oncol; 2012 May; 40(5):1423-30. PubMed ID: 22293932
[TBL] [Abstract][Full Text] [Related]
3. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC.
Aoki T; Ohnishi H; Oda Y; Tadokoro M; Sasao M; Kato H; Hattori K; Ohgushi H
Tissue Eng Part A; 2010 Jul; 16(7):2197-206. PubMed ID: 20146561
[TBL] [Abstract][Full Text] [Related]
5. Emerging methods for preparing iPS cells.
Miyazaki S; Yamamoto H; Miyoshi N; Takahashi H; Suzuki Y; Haraguchi N; Ishii H; Doki Y; Mori M
Jpn J Clin Oncol; 2012 Sep; 42(9):773-9. PubMed ID: 22826352
[TBL] [Abstract][Full Text] [Related]
6. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.
Huangfu D; Osafune K; Maehr R; Guo W; Eijkelenboom A; Chen S; Muhlestein W; Melton DA
Nat Biotechnol; 2008 Nov; 26(11):1269-75. PubMed ID: 18849973
[TBL] [Abstract][Full Text] [Related]
7. Dicer 1, ribonuclease type III modulates a reprogramming effect in colorectal cancer cells.
Dewi DL; Ishii H; Haraguchi N; Nishikawa S; Kano Y; Fukusumi T; Ozaki M; Saito T; Sakai D; Satoh T; Doki Y; Mori M
Int J Mol Med; 2012 Jun; 29(6):1060-4. PubMed ID: 22446887
[TBL] [Abstract][Full Text] [Related]
8. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
10. Induced pluripotency with endogenous and inducible genes.
Duinsbergen D; Eriksson M; 't Hoen PA; Frisén J; Mikkers H
Exp Cell Res; 2008 Oct; 314(17):3255-63. PubMed ID: 18656469
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of c-Myc expression inhibits the invasion of bile duct carcinoma cells.
Li ZR; Wu YF; Ma CY; Nie SD; Mao XH; Shi YZ
Cell Biol Int; 2011 Aug; 35(8):799-802. PubMed ID: 21557726
[TBL] [Abstract][Full Text] [Related]
12. A Cancer Reprogramming Method Using MicroRNAs as a Novel Therapeutic Approach against Colon Cancer: Research for Reprogramming of Cancer Cells by MicroRNAs.
Miyazaki S; Yamamoto H; Miyoshi N; Wu X; Ogawa H; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Konno M; Doki Y; Mori M; Ishii H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1394-401. PubMed ID: 25384704
[TBL] [Abstract][Full Text] [Related]
13. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.
Nakagawa M; Koyanagi M; Tanabe K; Takahashi K; Ichisaka T; Aoi T; Okita K; Mochiduki Y; Takizawa N; Yamanaka S
Nat Biotechnol; 2008 Jan; 26(1):101-6. PubMed ID: 18059259
[TBL] [Abstract][Full Text] [Related]
14. Increased reprogramming capacity of mouse liver progenitor cells, compared with differentiated liver cells, requires the BAF complex.
Kleger A; Mahaddalkar PU; Katz SF; Lechel A; Joo JY; Loya K; Lin Q; Hartmann D; Liebau S; Kraus JM; Cantz T; Kestler HA; Zaehres H; Schöler H; Rudolph KL
Gastroenterology; 2012 Apr; 142(4):907-17. PubMed ID: 22245845
[TBL] [Abstract][Full Text] [Related]
15. Expression and activation of the reprogramming transcription factors.
Guo J; Li ZC; Feng YH
Biochem Biophys Res Commun; 2009 Dec; 390(4):1081-6. PubMed ID: 19900408
[TBL] [Abstract][Full Text] [Related]
16. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
[TBL] [Abstract][Full Text] [Related]
17. Generation of pig induced pluripotent stem cells with a drug-inducible system.
Wu Z; Chen J; Ren J; Bao L; Liao J; Cui C; Rao L; Li H; Gu Y; Dai H; Zhu H; Teng X; Cheng L; Xiao L
J Mol Cell Biol; 2009 Oct; 1(1):46-54. PubMed ID: 19502222
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic gene therapy combined with double suicide genes for human bile duct cancer in nude mouse models.
Kojima Y; Honda K; Hamada H; Kobayashi N
J Surg Res; 2009 Nov; 157(1):e63-70. PubMed ID: 19345377
[TBL] [Abstract][Full Text] [Related]
19. Using small molecules to improve generation of induced pluripotent stem cells from somatic cells.
Desponts C; Ding S
Methods Mol Biol; 2010; 636():207-18. PubMed ID: 20336525
[TBL] [Abstract][Full Text] [Related]
20. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]